Intervention thresholds for the treatment of osteoporosis: Comparison of different approaches to decision-making

Osteoporosis International

Volumn 8, Issue SUPPL. 1, 1998, Pages

  Epstein, R S ^a   Feng, W ^a   Hirsch, L J ^a   Kelly, M ^a  

^a Merck Medco Managed Care Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BONE DENSITY; BONE MINERAL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BONE DENSITY; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; FRACTURES, SPONTANEOUS; HEALTH CARE COSTS; HIP FRACTURES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0031745603     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Parchman ML. Small area variation analysis: a tool for primary care research. Fam Med 1995;27:272-6.
2. Cummings SR, Rubin SM, Black D. The future of hip fractures in the United States: numbers, costs, and potential effects of postmenopausal estrogen. Clin Orthop 1990;252:163-6.
3. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72-5.
4. Looker AC, Johnston CC, Wahner HW. Prevalence of low femoral bone density in older US women from NHANES III. J Bone Miner Res 1995;10:796-802.
5. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series. Geneva: WHO, 1994.
6. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41.
7. Mucha L, Manfredonia D, Kim M, Abbott T, Berger M. Calibrating SCORE: tailoring a prescreening instrument to your population. J Bone Miner Res 1997;12(Suppl 1):S176.
8. Chrischilles E, Shireman T, Wallace R. Costs and health effects of osteoporotic fractures. Bone 1994;15:377-86.
9. Kanis JA, McCloskey EV. Evaluation of the risk of hip fracture. Bone 1996;18:S127-32.
10. Cummings SR. Treatment thresholds for preventive therapy: a simplified example of therapy for prevention of hip fractures. Scand J Rheumatol 1996;25(Suppl 103):101-7.
11. Paulker SG, Kassirer JP The threshold approach to clinical decision making. N Engl J Med 1980;302:1109-17.
12. Sox HC, Blatt MA, Higgins MC, et al. Medical decision making. London: Butterworth-Heinemann, 1988.
13. Ray NF, Chan JK, Thamer M, Melton LJ. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporotic Foundation. J Bone Miner Res 1997;12:24-35.
14. Ray WA, Griffin R, Baugh DK. Mortality following hip fractures before and after implementation of the prospective payment system. Arch Intern Med 1990;150:2109-14.
15. Jonsson B, Christiansen C, Johnell O, Hedbrandt J. Cost-effectiveness of fracture prevention in established osteoporosis. Osteoporos Int 1995;5:136-42.
16. Glick H. Cost effectiveness analysis based on evidence from trials Drug Information Association Meeting 1997. International policies in health economics, state of play and future direction for pharmaceuticals.
17. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med J 1992;146:473-81.
18. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
19. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1538-41.
20. Cummings SR, Black DM, Thompson DE. Alendronate reduces the risk of vertebral fractures in women without pre-existing vertebral fractures: results of the fracture intervention trial. J Bone Miner Res 1997;12(Suppl I):S149.